Cognitive Deficits for Chemo-Treated Breast Cancer Patients

This article originally appeared here.
Cognitive Deficits for Chemo-Treated Breast Cancer Patients
Cognitive Deficits for Chemo-Treated Breast Cancer Patients

(HealthDay News) -- Breast cancer survivors who were previously treated with chemotherapy experience small cognitive deficits in the domains of verbal ability and visuospatial ability, according to a study published online Aug. 27 in the Journal of Clinical Oncology.

To examine the long-term cognitive impact of chemotherapy, Heather S.L. Jim, Ph.D., from H. Lee Moffit Cancer Center in Tampa, Fla., and colleagues conducted a meta-analysis of 17 studies involving 807 patients previously treated with standard-dose chemotherapy for breast cancer.

The researchers found that, compared with controls or prechemotherapy baseline values, patients treated with chemotherapy had significant deficits in cognitive functioning in the domains of verbal ability (g, −0.19) and visuospatial ability (g, −0.27). Chemotherapy treatment correlated with significantly worse verbal ability compared with non-cancer controls and significantly worse visuospatial ability compared with patients treated without chemotherapy. There was no moderating effect for age, education, time since treatment, or endocrine therapy.

"Results indicate that, on average, observed cognitive deficits in patients with breast cancer previously treated with chemotherapy are small in magnitude and limited to the domains of verbal ability and visuospatial ability," the authors write. "This information can be used to inform interventions to educate patients with breast cancer regarding the long-term impact of chemotherapy on cognitive functioning."

Abstract
Full Text (subscription or payment may be required)
Editorial

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs